Candida nivariensis isolated from an Indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis

Journal of Clinical Microbiology

Volumn 46, Issue 1, 2008, Pages 388-391

  Wahyuningsih, Retno ^a,d   Sahbandar, Ivo N ^a   Theelen, Bart ^b   Hagen, Ferry ^b   Poot, Gé ^b   Meis, Jacques F ^c   Rozalyani, Anna ^a   Sjam, Ridhawati ^a   Widodo, Djoko ^a   Djauzi, Samsuridjal ^a   Boekhout, Teun ^b,e  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d CHRISTIAN UNIVERSITY OF INDONESIA   (Indonesia)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 [3 [4 (4 CYANOPHENYL) 2 THIAZOLYL] 2 (2,5 DIFLUOROPHENYL) 2 HYDROXYBUTYL] 4 [1 [N METHYL N [3 [2 (METHYLAMINO)ACETOXYMETHYL] 2 PYRIDINYL]CARBAMOYLOXY]ETHYL] 1H 1,2,4 TRIAZOL 4 IUM CHLORIDE; 4 [2 [2 (2,5 DIFLUOROPHENYL) 2 HYDROXY 1 METHYL 3 (1H 1,2,4 TRIAZOL 1 YL)PROPYL] 4 THIAZOLYL]BENZONITRILE; AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ADULT; ARTICLE; CANDIDA; CANDIDA NIVARIENSIS; CASE REPORT; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDONESIA; MALE; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; OROPHARYNX CANDIDIASIS; PRIORITY JOURNAL;

ADULT; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; HIV INFECTIONS; HUMANS; INDONESIA; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MYCOLOGICAL TYPING TECHNIQUES; PHARYNGITIS; SEQUENCE ANALYSIS, DNA;

CANDIDA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 38149113811     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01660-07     Document Type: Article

References (17)

1. Alcoba-Flórez, J., S. Méndez-Álvarez, J. Cano, J. Guarro, E. Pérez-Roth, and M. del Pilar Arévalo. 2005. Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J. Clin. Microbiol. 43:4107-4111.
2. Alcoba-Flórez, J., M. del Pilar Arévalo, F. J. González-Paredes, J. Cano, J. Guarro, E. Pérez-Roth, and S. Méndez-Álvarez. 2005. PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast. J. Clin. Microbiol. 43:6194-6196.
3. Bautista-Muñoz, C., X. M. Boldo, L. Villa-Tanaca, and C. Hernández-Rodríguez. 2003. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J. Clin. Microbiol. 41:414-420.
4. Borst, A., B. Theelen, E. Reinders, T. Boekhout, A. C. Fluit, and P. H. M. Savelkoul. 2003. Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis. J. Clin. Microbiol. 41:1357-1362.
5. Bravo, I. M., M. Correnti, L. Escalona, M. Perrone, A. Brito, V. Tovar, and H. Rivera. 2006. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population. Med. Oral. Patol. Oral. Cir. Bucal. 11:E1-E5.
6. Coleman, D. C., D. J. Sullivan, D. E. Bennet, G. P. Moran, H. J. Barry, and D. B. Shanley. 1997. Candidisasis: the emergence of novel species, Candida dubliniensis. AIDS 11:557-566.
7. Coogan, M. M., J. Greenspan, and S. J. Challacombe. 2005. Oral lesion in infection with human immunodeficiency virus. Bull. W. H. O. 83:700-706.
8. Correia, A., P. Sampaio, S. James, and C. Pais. 2006. Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int. J. Syst. Evol. Microbiol. 56:313-317.
9. de Repentigny, L., D. Lewandowski, and P. Jolicoeur. 2004. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin. Microbiol. Rev. 17:729-759.
10. Fujita, S., Y. Senda, T. Iwagami, H. Miyazaki, Y. Oota, H. Takada, K. Yamada, and M. Kawano. 2007. Catheter-related fungemia due to fluconazole-resistant Candida nivariensis. J. Clin. Microbiol. 45:3459-3461.
11. Meyer, W., and T. G. Mitchell. 1995. Polymerase chain reaction fingerprinting in fungi using single primers specific to minisatellites and simple repetitive DNA sequences: strain variation in Cryptococcus neoformans. Electrophoresis 16:1648-1656.
12. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
13. Odds, F. C. 1988. Candida and candidiasis, 2nd ed. Bailliere Tindall, London, United Kingdom.
14. Okoli, I., C. A. Oyeka, K. J. Kwon-Chung, B. Theelen, V. Robert, J. Z. Groenewald, D. C. McFadden, A. Casadevall, and T. Boekhout. 2006. Cryptotrichosporon anacardii gen. nov., sp. nov., a new trichosporonoid capsulate basidiomycetous yeast from Nigeria that is able to form melanin on Niger seed agar. FEMS Yeast Res. 7:339-350.
15. Pfaller, M. A., S. A. Messer, L. Boyken, S. Tendolkar, R. J. Hollis, and D. J. Diekema. 2004. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systematically active antifungal agents: a global assessment from the ARTEMIS antifungal surveillance program conducted in 2001 and 2002. J. Clin. Microbiol. 42:3142-3146.
16. Ruhnke, M. 2002. Skin and mucous membrane infections, p. 307-325. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, DC.
17. Smith, M. T., A. W. A. M. de Cock, G. A. Poot, and H. Y. Steensma. 1995. Genome comparisons in the yeastlike fungal genus Galactomyces Redhead et Malloch. Int. J. Syst. Bacteriol. 45:826-831.